AOD9604 5MG - Hubio Pharm
Optimize your metabolic profile with AOD9604, a highly targeted peptide designed for efficient fat oxidation. If you are looking for a solution to reduce abdominal fat without the side effects of increased hunger or elevated cortisol, this formula provides a professional-grade solution for weight management and metabolic support.
Specifications
| Active Substance | Anti-Obesity Drug-9 604 |
| Form | 1 vial x 5 mg + 1 vial x 2 ml bac.water |
| Manufacturer | Hubio Pharm |
Description & Mechanism of Action
AOD9604, also known as Tyr-hGH Frag 176-191, is a specialized peptide derived from the amino acid sequence of Growth Hormone. Unlike full-length HGH, this modified peptide focuses specifically on the 176-191 amino acid sequence, providing the fat-burning benefits of growth hormone without the accompanying tissue-growth effects.
The mechanism of action is unique: AOD9604 stimulates lipolysis (the breakdown of fats) and promotes the release of fat from adipose cells, particularly targeting more obese cells. It works by activating fat oxidation through a pathway that is independent of the standard hGH receptor. This allows for the reduction of abdominal fat stores without affecting blood sugar levels or stimulating excessive muscle growth.
For those interested in regenerative support, AOD9604 has also shown favorable results in laboratory settings regarding cartilage repair, especially when used in conjunction with BPC-157. Its ability to target fat-burning without the metabolic downsides of traditional HGH makes it a standout in the peptide industry.
FAQ
Does AOD9604 affect appetite?
No, unlike many other GH-related peptides, AOD9604 does not increase hunger or the desire to overeat, making it ideal for calorie-controlled diets.
How does it impact blood sugar?
AOD9604 has been shown to have no negative effect on carbohydrate metabolism or blood sugar levels, providing a safer profile than full-length HGH.
What is the safety profile of this product?
AOD9604 has a very favorable safety and tolerability profile. It has even obtained Human GRAS (Generally Recognized as AS Safe) status in the USA, with studies showing no serious adverse events related to its intake.
What is the history of AOD9604?
The peptide was originally developed by Professor Frank Ng at Monash University in Australia. It was designed specifically to capture the fat-burning benefits of human growth hormone without the side effects of increased growth or cortisol.